56 related articles for article (PubMed ID: 3037069)
1. Tissue-dependent alpha adrenoceptor activity of buspirone and related compounds.
Rimele TJ; Henry DE; Lee DK; Geiger G; Heaslip RJ; Grimes D
J Pharmacol Exp Ther; 1987 Jun; 241(3):771-8. PubMed ID: 3037069
[TBL] [Abstract][Full Text] [Related]
2. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein.
Flavahan NA; Rimele TJ; Cooke JP; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Sep; 230(3):699-705. PubMed ID: 6088763
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats.
Castillo C; Bobadilla RA; Ibarra M; Castillo EF; Hong E
Arch Med Res; 1995; 26(3):251-5. PubMed ID: 8580676
[TBL] [Abstract][Full Text] [Related]
4. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
Bianchi G; Caccia S; Della Vedova F; Garattini S
Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
[TBL] [Abstract][Full Text] [Related]
5. Characterization of alpha-adrenoceptors in rat and guinea pig tissues using radiolabeled agonists and antagonists.
Jarrott B; Summers RJ; Culvenor AJ; Louis WJ
Circ Res; 1980 Jun; 46(6 Pt 2):I15-20. PubMed ID: 6247087
[TBL] [Abstract][Full Text] [Related]
6. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
7. Alpha adrenergic receptor subtype associated with receptor binding, Ca++ influx, Ca++ release and contractile events in the rabbit aorta.
Awad R; Payne R; Deth RC
J Pharmacol Exp Ther; 1983 Oct; 227(1):60-7. PubMed ID: 6312022
[TBL] [Abstract][Full Text] [Related]
8. alpha2B-adrenoceptor agonist ST-91 antagonizes beta2-adrenoceptor-mediated relaxation in rat mesenteric artery rings.
Kató E; Lipták L; Shujaa N; Mátyus P; Gyires K; Rónai AZ
Eur J Pharmacol; 2008 Feb; 580(3):361-5. PubMed ID: 18054907
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in rabbit papillary muscle.
Aass H; Skomedal T; Osnes JB
J Pharmacol Exp Ther; 1983 Aug; 226(2):572-8. PubMed ID: 6308213
[TBL] [Abstract][Full Text] [Related]
11. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.
Kenakin TP
J Pharmacol Exp Ther; 1981 Feb; 216(2):210-9. PubMed ID: 6109772
[TBL] [Abstract][Full Text] [Related]
12. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
Minneman KP; Fox AW; Abel PW
Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex.
Minneman KP; Johnson RD
J Pharmacol Exp Ther; 1984 Aug; 230(2):317-23. PubMed ID: 6146710
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
Bolt GR; Itoh H; Lederis K; MacCannell KL
J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the calcium entry blocker D 600 on contractions of rat and guinea-pig aortas, elicited by various alpha-1 adrenoceptor agonists.
Beckeringh JJ; Thoolen MJ; de Jonge A; Wilffert B; Timmermans PB; van Zwieten PA
J Pharmacol Exp Ther; 1984 May; 229(2):515-21. PubMed ID: 6143818
[TBL] [Abstract][Full Text] [Related]
16. The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metabolite.
Tatarczyńska E; Pawłowski L; Chojnacka-Wójcik E; Maj J
Pol J Pharmacol Pharm; 1989; 41(1):51-61. PubMed ID: 2587437
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
[TBL] [Abstract][Full Text] [Related]
18. Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve.
Oriowo MA; Bevan JA; Bevan RD
J Pharmacol Exp Ther; 1989 Oct; 251(1):16-20. PubMed ID: 2552071
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen.
Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
J Psychopharmacol; 1990 Jan; 4(4):204-9. PubMed ID: 22281849
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems.
Giral P; Soubrie P; Puech AJ
Eur J Pharmacol; 1987 Jan; 134(1):113-6. PubMed ID: 2881793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
